STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[SCHEDULE 13G/A] Immatics N.V. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A
Rhea-AI Filing Summary

Baker Bros. Advisors and affiliated persons report beneficial ownership of 10,168,901 ordinary shares of Immatics N.V., representing 8.4% of the company’s outstanding common stock based on 121,550,169 shares outstanding as reported in the issuer's public filing. The reported holdings are held by two funds (Life Sciences and 667) for which the adviser has sole voting and dispositive power, with 9,354,564 shares held by Life Sciences and 814,337 shares held by 667. This filing amends prior Schedule 13G disclosures and clarifies ownership and control relationships among the adviser, its GP and two individual reporting persons.

Positive
  • Clear disclosure of aggregate beneficial ownership of 10,168,901 shares (8.4%), improving transparency for investors
  • Confirmed sole voting and dispositive power by the adviser over the shares held by the Funds, clarifying who controls voting and disposition
Negative
  • None.

Insights

TL;DR: A prominent investment adviser discloses an 8.4% passive stake, with sole voting and dispositive control over the shares held by its funds.

The filing shows Baker Bros. Advisors (and its GP and principals) exercises sole voting and dispositive authority over 10,168,901 shares of Immatics, equal to 8.4% of the reported outstanding stock. The stake is concentrated in two funds with clear allocation between them (9.35M and 0.81M). For investors, this disclosure clarifies ownership structure and confirms the adviser’s control over votes and dispositions of the reported shares, consistent with prior Schedule 13G filings.

TL;DR: The amendment documents centralized authority within the adviser structure and identifies controlling persons for shareholder voting.

The amendment highlights that the funds’ general partners relinquished discretion to the adviser, making the adviser the sole decision-maker for these holdings; the GP and two individuals are disclosed as related reporting persons. This structure is important for governance transparency because it identifies who can direct voting on corporate matters and confirms the passive-status filing framework under Rule 13d-1.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Baker Bros. Advisors LP
Signature:/s/ Scott L. Lessing
Name/Title:By: Baker Bros. Advisors (GP) LLC, its general partner Scott L. Lessing/ President
Date:08/14/2025
Baker Bros. Advisors (GP) LLC
Signature:/s/ Scott L. Lessing
Name/Title:Scott L. Lessing/ President
Date:08/14/2025
Julian C. Baker
Signature:/s/ Julian C. Baker
Name/Title:JULIAN C. BAKER
Date:08/14/2025
Felix J. Baker
Signature:/s/ Felix J. Baker
Name/Title:FELIX J. BAKER
Date:08/14/2025

FAQ

How many Immatics (IMTX) shares does Baker Bros. Advisors beneficially own?

The reporting persons beneficially own 10,168,901 shares, representing 8.4% of Immatics' outstanding common stock as reported.

What percentage of Immatics does the 667 fund and Life Sciences fund each own?

The filing states 667 owns 0.7% and Life Sciences owns 7.7% of the outstanding common stock, together totaling 8.4%.

Who has voting and dispositive power over these Immatics shares?

Baker Bros. Advisors is reported to have sole voting and sole dispositive power over the shares held by the Funds; shared powers are reported as 0.

Which reporting persons are named on this Schedule 13G/A for IMTX?

The filing lists Baker Bros. Advisors LP, Baker Bros. Advisors (GP) LLC, and individuals Julian C. Baker and Felix J. Baker as reporting persons.

On what outstanding share base is the 8.4% calculated?

The percentage is calculated using 121,550,169 shares outstanding, as reported in the issuer's referenced public filing.
Immatics N.V

NASDAQ:IMTX

IMTX Rankings

IMTX Latest News

IMTX Latest SEC Filings

IMTX Stock Data

1.23B
88.81M
22.85%
79.55%
2.95%
Biotechnology
Healthcare
Link
Germany
Tübingen